We are excited to announce that the 2nd International Workshop on Myelodysplastic Syndromes (iwMDS) will take place in person in Dubrovnik, Croatia, on 7 – 9 July, 2023. In keeping with the ethos of iwMDS, the emphasis of the workshop will be on short, high-level presentations, sessions of interactive debate and panel discussions.
About the meeting
07 - 09
iwMDS is an annual workshop/think-tank bringing together leading international clinical and translational research minds in myelodysplastic syndromes in a face-to-face forum. Discussions around the current state-of-the-art in clinical care and research aim to set the agenda for clinical and translational research priorities for the future, in collaboration with relevant stakeholders.
- Create annual opportunity for scientific exchange of ideas, knowledge, and research in myelodysplastic syndromes
- Enhance networking and inter-disciplinary collaborations
- Create a platform for a united voice from scientific/research community to provide focused input into the research priorities
- Improve clinical trial design and conduct to be more efficient and inclusive through robust interactions with industry partners, regulators, and patient advocacy groups
Our Media Partners
We are pleased to have the Video Journal of Hematological Oncology (VJHemOnc) as our official media partners, providing on-demand coverage that can be viewed in the Meeting Highlights tab.
VJHemOnc are global, open-access video journals, dedicated to providing trusted and up-to-date independent medical education in order to improve the awareness of advances in the management of hematological and solid cancers and share best practice within the oncology community.
The goal of the journals is to expedite learning through the sharing of new data and expert opinion, and to rapidly disseminate the latest news and information to healthcare professionals, worldwide, in a range of innovative digital media – including video and blog formats.
VJHemOnc content is led by editorial boards of highly respected thought leaders with a combined expertise that spans the spectrum of hematological and solid cancers. All content is created and published under the guidance of these boards of world-leading experts.
For more information please see VJHemOnc.com